ImmuCell Corporation Total Long-Term Debt
ImmuCell Corporation (ICCC) had Total Long-Term Debt of $8.30 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2026-08-13
- 2026-06-30: Long-term Debt $8.30M.
- 2026-03-31: Long-term Debt $8.70M.
- 2025-12-31: Long-term Debt $9.10M.
- 2025-09-30: Long-term Debt $9.49M.
| Period end | Long-term Debt |
|---|---|
| 2026-06-30 | $8.30M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $8.70M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $9.10M 10-K · filed 2026-03-30 |
| 2025-09-30 | $9.49M 10-Q · filed 2025-11-13 |
| 2025-03-31 | $10.25M 10-Q · filed 2025-05-14 |
| 2023-09-30 | $12.32M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $9.73M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $9.98M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $10.23M 10-K · filed 2023-03-29 |
| 2022-09-30 | $10.48M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $10.70M 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $697.79K 10-Q/A · filed 2022-11-21 |
| 2021-12-31 | $812.21K 10-K · filed 2022-03-30 |
| 2021-09-30 | $192.93K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $383.31K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $9.31M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $9.50M 10-K · filed 2021-03-30 |
| 2020-09-30 | $9.72M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $9.86M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $8.56M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $8.42M 10-K · filed 2020-03-27 |
| 2019-09-30 | $8.63M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $8.85M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $9.06M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $9.27M 10-K · filed 2019-03-22 |
| 2018-09-30 | $9.48M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $9.12M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $9.19M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $8.96M 10-K · filed 2018-03-29 |
| 2014-06-30 | $838.76K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $882.49K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $929.23K 10-Q · filed 2014-08-13 |
| 2013-09-30 | $987.89K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $1.04M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $1.11M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $1.17M 10-K · filed 2014-03-26 |
| 2012-09-30 | $1.22M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $1.26M 10-Q/A · filed 2012-09-07 |
| 2011-12-31 | $1.34M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |